Theraflu Max 1000 mg/12,2 mg/200 mg prašak za oralnu otopinu
Name | Theraflu Max 1000 mg/12,2 mg/200 mg prašak za oralnu otopinu |
---|---|
Marketing Authorisation Number | HR-H-102729071 |
Active Substance | paracetamol fenilefrinklorid gvaifenezin |
Composition | svaka jednodozna vrećica sadrži 1000 mg paracetamola, 12,2 mg fenilefrinklorida (što odgovara 10 mg fenilefrin baze) i 200 mg gvaifenezina |
Pharmaceutical Form | prašak za oralnu otopinu |
Packaging [MA Number for Packaging] | 10 vrećica s praškom, u kutiji [HR-H-102729071-01] |
Manufacturer | GlaxoSmithKline Consumer Healtcare GmbH & Co. KG, München, Njemačka Haleon Germany GmbH, München, Njemačka |
Marketing Authorisation Holder | GlaxoSmithKline Dungarvan Ltd., Knockbrack, Dungarvan, County Waterford, Irska |
Marketing Authorisation Date | 06.08.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/52 |
Registration Number | 381-12-01/38-21-03 |
Prescription | bez recepta |
Distribution | u ljekarni |
Advertising to general public | dopušteno |
ATC Code | N02BE51 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |